Wave Life Sciences (WVE) Income from Continuing Operations (2016 - 2025)
Historic Income from Continuing Operations for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to -$53.9 million.
- Wave Life Sciences' Income from Continuing Operations rose 1283.26% to -$53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$121.9 million, marking a year-over-year increase of 1444.79%. This contributed to the annual value of -$97.0 million for FY2024, which is 6867.14% down from last year.
- Wave Life Sciences' Income from Continuing Operations amounted to -$53.9 million in Q3 2025, which was up 1283.26% from -$50.5 million recorded in Q2 2025.
- In the past 5 years, Wave Life Sciences' Income from Continuing Operations registered a high of $29.3 million during Q4 2024, and its lowest value of -$61.8 million during Q3 2024.
- Over the past 5 years, Wave Life Sciences' median Income from Continuing Operations value was -$37.8 million (recorded in 2022), while the average stood at -$31.0 million.
- Over the last 5 years, Wave Life Sciences' Income from Continuing Operations had its largest YoY gain of 27969.78% in 2024, and its largest YoY loss of 94920.96% in 2024.
- Quarter analysis of 5 years shows Wave Life Sciences' Income from Continuing Operations stood at -$34.8 million in 2021, then dropped by 25.65% to -$43.7 million in 2022, then skyrocketed by 62.76% to -$16.3 million in 2023, then surged by 279.7% to $29.3 million in 2024, then tumbled by 284.09% to -$53.9 million in 2025.
- Its last three reported values are -$53.9 million in Q3 2025, -$50.5 million for Q2 2025, and -$46.9 million during Q1 2025.